IRIS
VAGO, LUCA ALDO EDOARDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.198
AS - Asia 4.983
NA - Nord America 2.763
SA - Sud America 1.557
AF - Africa 115
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 2
Totale 14.633
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 3.076
US - Stati Uniti d'America 2.623
SG - Singapore 1.748
CN - Cina 1.479
BR - Brasile 1.295
HK - Hong Kong 742
SE - Svezia 637
IT - Italia 570
VN - Vietnam 564
FR - Francia 266
DE - Germania 199
GB - Regno Unito 102
AR - Argentina 97
IN - India 76
FI - Finlandia 72
JP - Giappone 61
NL - Olanda 58
AT - Austria 57
EC - Ecuador 57
CA - Canada 55
BD - Bangladesh 53
MX - Messico 49
ID - Indonesia 41
IQ - Iraq 38
ZA - Sudafrica 38
PL - Polonia 31
CO - Colombia 30
TR - Turchia 30
PK - Pakistan 25
PY - Paraguay 24
ES - Italia 23
IE - Irlanda 19
UZ - Uzbekistan 19
SA - Arabia Saudita 18
CL - Cile 17
TN - Tunisia 17
VE - Venezuela 17
MA - Marocco 16
AU - Australia 15
UA - Ucraina 15
DZ - Algeria 12
IR - Iran 12
EG - Egitto 11
HU - Ungheria 11
BE - Belgio 10
PE - Perù 9
CH - Svizzera 8
KE - Kenya 8
LT - Lituania 8
MY - Malesia 8
HN - Honduras 7
JM - Giamaica 7
PH - Filippine 7
UY - Uruguay 7
AE - Emirati Arabi Uniti 6
LB - Libano 6
AZ - Azerbaigian 5
IL - Israele 5
JO - Giordania 5
KW - Kuwait 5
KZ - Kazakistan 5
NP - Nepal 5
RS - Serbia 5
AL - Albania 4
BA - Bosnia-Erzegovina 4
NI - Nicaragua 4
BO - Bolivia 3
BY - Bielorussia 3
CR - Costa Rica 3
CZ - Repubblica Ceca 3
DK - Danimarca 3
GE - Georgia 3
GT - Guatemala 3
SK - Slovacchia (Repubblica Slovacca) 3
SV - El Salvador 3
TH - Thailandia 3
BB - Barbados 2
BH - Bahrain 2
CY - Cipro 2
ET - Etiopia 2
GA - Gabon 2
GR - Grecia 2
MD - Moldavia 2
PA - Panama 2
PT - Portogallo 2
SC - Seychelles 2
SY - Repubblica araba siriana 2
TG - Togo 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
AM - Armenia 1
BG - Bulgaria 1
BQ - ???statistics.table.value.countryCode.BQ??? 1
BW - Botswana 1
CI - Costa d'Avorio 1
DO - Repubblica Dominicana 1
GD - Grenada 1
GH - Ghana 1
GY - Guiana 1
HR - Croazia 1
Totale 14.621
Salva come PNG Salva come JPEG
Città #
Singapore 790
Hong Kong 668
Moscow 654
Dallas 383
Ashburn 370
Shanghai 329
San Jose 259
Hefei 252
Lawrence 225
Princeton 225
Lauterbourg 223
Ho Chi Minh City 211
Milan 183
Beijing 176
São Paulo 128
New York 115
Hanoi 106
Los Angeles 65
Nuremberg 62
Helsinki 43
Boardman 35
Rio de Janeiro 34
Santa Clara 32
Tokyo 32
Denver 29
Munich 29
Orem 29
Brasília 28
Belo Horizonte 26
Da Nang 26
Guangzhou 26
Rome 26
Vienna 26
Haiphong 24
Warsaw 24
Johannesburg 23
Brooklyn 22
Quito 22
Cesano Boscone 21
Montreal 21
Chennai 20
Guayaquil 20
Stockholm 20
Curitiba 19
Atlanta 18
Poplar 18
Dublin 17
London 17
Tianjin 17
Baghdad 16
Manchester 16
Tashkent 16
Turku 16
Shenzhen 15
Council Bluffs 14
Frankfurt am Main 14
Houston 14
Hải Dương 14
Salvador 14
Amsterdam 13
Bergamo 13
Ankara 12
Campinas 12
Mexico City 12
Phoenix 12
Porto Alegre 12
Toronto 12
Washington 12
Caxias do Sul 11
Hangzhou 11
Lappeenranta 11
Recife 11
Seattle 11
Bologna 10
Bolzano 10
Chaoyang 10
Chicago 10
Dhaka 10
Duque de Caxias 10
Nova Iguaçu 10
San Francisco 10
Shijiazhuang 10
Turin 10
Budapest 9
Guarulhos 9
Naples 9
Ninh Bình 9
Reston 9
São Gonçalo 9
Uberlândia 9
Aracaju 8
Biên Hòa 8
Bogotá 8
Buenos Aires 8
Can Tho 8
Fortaleza 8
Franca 8
Lima 8
Montes Claros 8
Mumbai 8
Totale 6.725
Salva come PNG Salva come JPEG
Nome #
Loss of mismatched HLA in leukemia after stem-cell transplantation 182
Incidence, risk factors and clinical outcome of leukemia relapses with loss of the mismatched HLA after partially incompatible hematopoietic stem cell transplantation 161
Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II study 161
Dynamics of polyclonal immuno-reconstitution after allogeneic transplant with post-transplant cyclophosphamide and letermovir 160
Neural stem cell transplantation in patients with progressive multiple sclerosis: an open-label, phase 1 study 158
A case of T-cell acute lymphoblastic leukemia in retroviral gene therapy for ADA-SCID 158
CRISPR-based gene disruption and integration of high-avidity, WT1-specific T cell receptors improve antitumor T cell function 140
Sirolimus-based graft-versus-host disease prophylaxis promotes the in vivo expansion of regulatory T cells and permits peripheral blood stem cell transplantation from haploidentical donors 134
A Mechanistic Role For Mir-126, a Hematopoietic Stem Cell Microrna, In Acute Leukemias 134
TIM-3, LAG-3, or 2B4 gene disruptions increase the anti-tumor response of engineered T cells 132
Cytomegalovirus-specific T cells restricted for shared and donor human leukocyte antigens differentially impact on Cytomegalovirus reactivation risk after allogeneichematopoietic stem cell transplantation 123
Longitudinal single-cell profiling of chemotherapy response in acute myeloid leukemia 120
Allogeneic hematopoietic stem cell transplantation in patients older than 65 years with acute myeloid leukemia and myelodysplastic syndrome: a 15-year experience 116
Results from the HLA COVID-Italia study: An unexpected correlation between HLA-DP antigen load and COVID-19 severity 115
MODELING ADOPTIVE IMMUNOTHERAPY IN MOUSE-HUMANS CHIMERAS TO IDENTIFY NOVEL MECHANISMS OF LEUKEMIA IMMUNOEDITING 115
A new tool for rapid and reliable diagnosis of HLA loss relapses after HSCT 114
NON-GENOMIC ALTERATIONS IN ANTIGEN PRESENTATION AND T CELL COSTIMULATION ARE DISTINCT DRIVERS OF LEUKEMIA IMMUNE ESCAPE AND RELAPSE AFTER HEMATOPOIETIC CELL TRANSPLANTATION 111
Allogeneic hematopoietic stem cell transplantation for neuromyelitis optica. 108
Human herpesvirus 6-specific T-cell immunity in allogeneic hematopoietic stem cell transplant recipients 104
CRISPR/CAS9-BASED GENOME EDITING TO MODEL THE ANTI-LEUKEMIA IMMUNE RESPONSE AND IDENTIFY ITS MOLECULAR PLAYERS 102
Allogeneic haematopoietic stem cell transplantation in refractory neuromyelitis optica spectrum disorders 101
Azacitidine and donor lymphocytes infusions in acute myeloid leukemia and myelodysplastic syndrome relapsed after allogeneic hematopoietic stem cell transplantation from alternative donors 99
Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic Syndromes 98
Atypical acute myeloid leukemia-specific transcripts generate shared and immunogenic MHC class-I-associated epitopes 98
Impact of predicted HLA class I immunopeptidome on viral reservoir in a cohort of people living with HIV in Italy 97
Graft-versus-lymphoma effect inside the central nervous system in a patient with extranodal natural killer/T-cell lymphoma, nasal type 94
Pre-existing immunity drives the response to neoadjuvant chemotherapy in esophageal adenocarcinoma 92
The transcription factor HIF2α partakes in the differentiation block of acute myeloid leukemia 92
Integrated Multiomic Profiling Identifies the Epigenetic Regulator PRC2 as a Therapeutic Target to Counteract Leukemia Immune Escape and Relapse 92
Beneficial role of CD8+ T-cell reconstitution after HLA-haploidentical stem cell transplantation for high-risk acute leukaemias: results from a clinico-biological EBMT registry study mostly in the T-cell-depleted setting 91
Targeting intracellular WT1 in AML with a novel RMF-peptide-MHC-specific T-cell bispecific antibody 90
Acute Myeloid Leukemia Relapses after Allogenenic HSCT Display a Distinctive Immune-Related Signature, with Frequent and Functionally Relevant Alterations in HLA Class II Antigen Presentation and T Cell Costimulation 88
Immune signature drives leukemia escape and relapse after hematopoietic cell transplantation 87
Allelic HLA Matching and Pair Origin Are Favorable Prognostic Factors for Unrelated Hematopoietic Stem Cell Transplantation in Neoplastic Hematologic Diseases: An Italian Analysis by the Gruppo Italiano Trapianto di Cellule Staminali e Terapie Cellulari, Italian Bone Marrow Donor Registry, and Associazione Italiana di Immunogenetica e Biologia dei Trapianti 87
Alterations in the genomic and transcriptional profile of leukemia upon the immune pressure of allogenic hematopoietic stem cell transplantation: tracking immunoediting by high-throughput techniques 85
Posttransplantation Cyclophosphamide- and Sirolimus-Based Graft-Versus-Host-Disease Prophylaxis in Allogeneic Stem Cell Transplant 85
Anidulafungin primary prophylaxis in 28 high-risk patients undergoing allogeneic haematopoietic stem cell transplantation: a single-centre experience 84
An Accelerated CD8+, but Not CD4+, T-Cell Reconstitution Associates with a More Favorable Outcome Following HLA-Haploidentical HSCT: Results from a Retrospective Study of the Cell Therapy and Immunobiology Working Party of the EBMT 84
Anidulafungin primary antifungal prophylaxis in 36 high-risk haematological patients undergoing haematopoietic stem cell transplantation 83
Quantitative polymerase chain reaction-based chimerism in bone marrow or peripheral blood to predict acute myeloid leukemia relapse in high-risk patients: results from the KIM-PB prospective study 83
An Accelerated CD8+, but Not CD4+, T -Cell Reconstitution Associates with a More Favorable Outcome Following HLA-Haploidentical HSCT: Results from a Retrospective Study of the Cell Therapy and Immunobiology Working Party of the EBMT 83
Adjuvant role of SeptiFast to improve the diagnosis of sepsis in a large cohort of hematological patients 81
Mechanisms of Leukemia Immune Evasion and Their Role in Relapse After Haploidentical Hematopoietic Cell Transplantation 81
Tracking genetically engineered lymphocytes long-term reveals the dynamics of T cell immunological memory 80
AN INNOVATIVE HUMANIZED MOUSE MODEL TO INVESTIGATE THE INTERPLAY BETWEEN IMMUNE SYSTEM AND ACUTE MYELOID LEUKEMIA IN ALLOGENEIC HSCT 80
QUANTITATIVE PCR-BASED CHIMERISM MONITORING IN BONE MARROW OR PERIPHERAL BLOOD TO PREDICT LEUKAEMIA RELAPSE IN HIGH-RISK PATIENTS: FINAL RESULTS OF THE KIM-PB PROSPECTIVE STUDY 77
NY-ESO-1 TCR single edited stem and central memory T cells to treat multiple myeloma without graft-versus-host disease 77
Antifungal Prophylaxis with Posaconazole in Allogeneic Hematopoietic Stem Cell Transplantation Using Sirolimus for Prevention of Graft-Versus-Host Disease 77
Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells 75
Longitudinal qPCR monitoring of nucleophosmin 1 mutations after allogeneic hematopoietic stem cell transplantation to predict AML relapse 75
ALLOGENEIC STEM CELL TRANSPLANTATION FOR HEMATOLOGIC MALIGNANCIES: 4GY TBI TO INTENSIFY TREOSULFAN AND FLUDARABINE-BASED CONDITIONING 75
Allogeneic haematopoietic stem cell transplantation in patients older than 65 years with high risk acute myeloid leukemia: results in 46 consecutive patients 75
Erratum: Tracking genetically engineered lymphocytes long-term reveals the dynamics of T cell immunological memory (Science Translational Medicine (2015) 7:319 (319er9)) 74
Bone marrow central memory and memory stem T-cell exhaustion in AML patients relapsing after HSCT 72
Immunoediting of the genomic and transcriptional profile of acute myeloid leukaemia in response to allogeneic haematopoietic stem cell transplantation 71
SUICIDE GENE TRANSFER INTO DONOR LYMPHOCYTES ALLOWS EARLY AND EFFECTIVE IMMUNE-RECONSTITUTION AFTER FAMILY HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR LEUKEMIAS: RESULTS OF THE TK007 STUDY 71
Genomic Loss of Mismatched Human Leukocyte Antigen and Leukemia Immune Escape From Haploidentical Graft-Versus-Leukemia 71
T Cell Suicide Gene Therapy Prompts Thymic Renewal in Adults After Haploidentical Hematopoietic Stem Cell Transplantation in the Absence of Post-Transplant Immunesuppression 70
Allogeneic Hematopoietic Stem Cell Transplantation For Severe Neuromyelitis Optica 70
Spontaneous remission of choroidal involvement by chronic myelomonocytic leukemia: a case report 69
The effect of donor-recipient KIR ligand incompatibility after haploidentical hematopoietic stem cell transplantation is overruled by biological characteristics of early reconstituting NK cells with impaired graft versus leukemia activity 69
Early and Effective Immune-Recovery by Gene-Engineered Lymphocytes after Haploidentical Transplantation for Leukemia Abate Late Transplant Mortality 69
Targeting WT1 reactivation in patients in complete remission after allogeneic haematopoietic stem cell transplantation for AML and MDS: results in 111 patients 68
Rapid and effective immune reconstitution with HSV-TK engineered donor lymphocyte add-backs after Haplo-HSCT 67
Nonpermissive HLA-DPB1 disparity is a significant independent risk factor for mortality after unrelated hematopoietic stem cell transplantation 67
PROFILING THE MUTATIONAL LANDSCAPE OF ACUTE MYELOID LEUKEMIA AT RELAPSE AFTER CHEMOTHERAPY AND ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION 67
TREOSULFAN-BASED CONDITIONING AND UNMANIPULATED PERIPHERAL BLOOD HAPLOIDENTICAL TRANSPLANTATION (HAPLOSCT) FOR PRIMARY REFRACTORY AND RELAPSED AML: RESULTS IN 63 PATIENTS 66
Experts' considerations on HLA-haploidentical stem cell transplantation 65
Droplet digital polymerase chain reaction for DNMT3A and IDH1/2 mutations to improve early detection of acute myeloid leukemia relapse after allogeneic hematopoietic stem cell transplantation 64
Immune monitoring in allogeneic hematopoietic stem cell transplant recipients: a survey from the EBMT-CTIWP 64
Sorafenib maintenance in FLT3-ITD mutated AML after allogeneic HCT: a real-world, single-center experience 64
Monitoring for virus-specific T-cell responses and viremia in allogeneic HSCT recipients: a survey from the EBMT Cellular Therapy & Immunobiology Working Party 63
Improving the Diagnostic Algorithm for Sepsis: Adjuvant Role of SeptiFast in 491 Consecutive Hematological Patients 62
Post-transplantation Cyclophosphamide and Sirolimus after Haploidentical Hematopoietic Stem Cell Transplantation Using a Treosulfan-based Myeloablative Conditioning and Peripheral Blood Stem Cells 61
Early molecular diagnosis of aspergillosis in a patient with acute myeloid leukaemia 61
Temporal, quantitative and functional characteristics of Single-KIR positive alloreactive NK cell recovery account for impaired graft versus leukemia activity after haploidentical HSCT 61
Genomic typing for patient-specific human leukocyte antigen-alleles is an efficient tool for relapse detection of high-risk hematopoietic malignancies after stem cell transplantation from alternative donors 61
Comparative evaluation of biological HLA-DPB1 mismatch models for survival and graft versus host disease prediction after unrelated donor hematopoietic cell transplantation 61
Tracking genetically engineered lymphocytes long-term reveals the dynamic of T-cell immunological memory 61
Generation of human memory stem T cells after haploidentical T-replete hematopoietic stem cell transplantation 60
Timing and rate of success in transplant of MUD searches through BMDW: the real case of CIC-813 in 2006–2009 60
Time of Origin and Environmental Drivers of Leukemia Immune Escape after Transplantation 60
MRD in Venetoclax-Based Treatment for AML: Does it Really Matter? 59
Improving the safety of cell therapy with the TK-suicide gene. 59
Human Herpesvirus 6 Infection Following Haploidentical Transplantation: Immune Recovery and Outcome 59
NK cell recovery after haploidentical HSCT with posttransplant cyclophosphamide: Dynamics and clinical implications 59
Loss of Mismatched HLA as a Mechanism of Leukemia Immune Escape in Family Haploidentical and Unrelated HSCT: Analysis of 103 Transplants From Alternative Donors 59
Frequency and targeted detection of HLA-DPB1 T cell epitope disparities relevant in unrelated hematopoietic stem cell transplantation 59
Facing the Rising Tide of Multidrug Resistant Gram-Negative Pathogens in Allogeneic HSCT with Nanosphere's Verigene((R)) System 58
Cytokine-induced killer cells are terminally differentiated activated CD8 cytotoxic T-EMRA lymphocytes 57
DAY-14 LAIP ON BONE MARROW PREDICTS COMPLETE RESPONSE AND DRIVE EARLY SALVAGE CHEMOTHERAPY IN AML: RESULTS OF MULTIPARAMETER FLOW CYTOMETRY AND WT1-RNA QUANTIFICATION 57
Enteric microbiome markers as early predictors of clinical outcome in allogeneic hematopoietic stem cell transplant (allo-HSCT): results of a prospective study in adult patients 56
Cytokine-induced killer cells are terminally differentiated activated CD8 cytotoxic T EMRA lymphocytes 56
Mutation at Positively Selected Positions in the Binding Site for HLA-C Shows That KIR2DL1 Is a More Refined but Less Adaptable NK Cell Receptor Than KIR2DL3 56
Kinetics of acute and chronic GvHD control by ganciclovir in-vivo HSV-TK suicide gene activation: long-term GvHD-free survival in 57 patients after haploidentical TK-cells 56
Early post-allogeneic transplantation WT1 transcript positivity predicts AML relapse 56
DROPLET DIGITAL PCR FOR DNMT3A AND IDH1/2 MUTATIONS TO IMPROVE EARLY DETECTION OF ACUTE MYELOID LEUKEMIA RELAPSE AFTER ALLOGENEIC HSCT 56
Integrating biological HLA-DPB1 mismatch models to predict survival after unrelated hematopoietic cell transplantation 55
Longitudinal microbiome profile associates with the risk of major transplant-related complications in allogeneic HSCT recipients 55
In vitro characterization of permissible HLA mismatches in allogeneic hematologic stem cell transplantation by use of autologous mixed lymphocyte reactions with retrovirally transduced CD40L-activated B cells 55
Totale 8.390
Salva come PNG Salva come JPEG
Categoria #
all - tutte 95.497
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 95.497
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022144 0 0 0 34 12 8 6 21 22 18 10 13
2022/20231.263 493 293 82 10 43 136 38 79 49 14 17 9
2023/2024670 32 29 61 66 44 87 106 56 12 23 30 124
2024/20253.424 429 66 62 86 89 256 431 390 614 510 240 251
2025/20269.221 740 755 732 1.540 668 266 778 651 2.790 301 0 0
Totale 14.926